NSW Cancer Research Education State-wide Seminar Series |
Early-onset bowel cancer – detection & treatment gains amid the biggest cancer killer in the under-50s
Tuesday 18 June, 12.30pm - 1.30pm | Online Webinar
The NSW Regional Cancer Research Network, in collaboration with the Maridulu Budyari Gumal (SPHERE) Cancer CAG and Sydney Cancer Partners host the 2024 NSW Cancer Research Education State-wide Seminar Series. These online seminars are held on the 3rd Tuesday of each month.
Session Information
A diagnosis of colorectal cancer is always life-changing but it is particularly devastating in the under-50s. This seminar will discuss the rising incidence of early colorectal cancer; the evolution of screening recommendations; the utility of advanced surgical options and real-world issues unique to those under-50 with colorectal cancer.
Speakers
Associate Professor Eleonora Feletto leads the Gastrointestinal Cancers Policy and Evaluation Stream at the Daffodil Centre, a joint venture between the University of Sydney and Cancer Council NSW. Her current work focuses on prevention and early detection of colorectal and liver cancer in Australia and overseas. The work of her team combines cancer epidemiology and predictive modelling to both understand cancer patterns and outcomes as well as project the future burden. She is currently working on major national projects assessing colorectal cancer control with a focus on improving participation in the National Bowel Cancer Screening Program.
Associate Professor Cherry Koh is a colorectal surgeon at RPA Hospital in Sydney. She is an academic surgeon with an interest in advanced colorectal cancer. She is the associate professor for surgical outcomes and is a part of Surgical Outcomes Research Centre (SOuRCe) at RPA.
Dr Sarah Sutherland is a medical oncologist at the Chris O’Brien Lifehouse who specialises in the treatment of gastro-intestinal malignancies. She is a senior lecturer at the University of Sydney and after completing a PHD in 2022 on Dendritic Cell vaccine therapy continues to participate in research with a focus on improving outcomes for patients with colorectal cancer.
Session Chair
Dr Alex Flynn is a Medical Oncologist undertaking her PhD with the University of Newcastle at the Hunter Medical Research Institute. She completed an undergraduate Bachelor of Science (Advanced Mathematics) and Bachelor of Medicine / Bachelor of Surgery MBBS (Hons) at the University of Sydney. She completed her specialty training in Medical Oncology (FRACP) across the Hunter New England & Central Coast LHDs, which has given her a broad experience of regional & rural medicine. Her PhD includes developing clinical evidence to individualise dosing of 5FU (5-fluorouracil) chemotherapy, so that every patient with colorectal cancer will receive a personalised dose with less side effects and longer survival. Finger **** testing should enable this to be accessible to patients outside of metropolitan areas. Her clinical trial concept was awarded “Best New Concept” at the 2023 AGITG ASM & her finger **** validation study is being supported by a NSWRCRN Translational Research Project Grant.
REGISTER HERE
Please select ‘NSW Regional Cancer Research Network’ as the Centre to which you belong.